Literature DB >> 21437706

[Infections with non-tuberculous mycobacteria in HIV-infected patients].

C Herzmann1, S Esser, C Lange.   

Abstract

Disseminated infections with non-tuberculous mycobacteria (NTM) are a life-threatening AIDS-defining illness. Localized infections include pulmonary and extra-pulmonary disease as well as the immune reconstitution inflammatory syndrome (IRIS). Furthermore cutaneous and subcutaneous manifestations of systemic NTM-Infections have been reported. Skin infections without involvement of other anatomical regions are predominantly caused by M. marinum and M. ulcerans. No association with HIV is proven for these two species. This article summarizes the diseases caused by this heterogeneous group of bacteria. The focus is on disseminated disease, dermatological manifestations and extra-pulmonary localized infections. Diagnostic challenges, therapeutic strategies and prognosis of NTM-infections are discussed.

Entities:  

Mesh:

Year:  2011        PMID: 21437706     DOI: 10.1007/s00105-010-2104-7

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  20 in total

Review 1.  An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases.

Authors:  David E Griffith; Timothy Aksamit; Barbara A Brown-Elliott; Antonino Catanzaro; Charles Daley; Fred Gordin; Steven M Holland; Robert Horsburgh; Gwen Huitt; Michael F Iademarco; Michael Iseman; Kenneth Olivier; Stephen Ruoss; C Fordham von Reyn; Richard J Wallace; Kevin Winthrop
Journal:  Am J Respir Crit Care Med       Date:  2007-02-15       Impact factor: 21.405

2.  Surveillance for AIDS-defining opportunistic illnesses, 1992-1997.

Authors:  J L Jones; D L Hanson; M S Dworkin; D L Alderton; P L Fleming; J E Kaplan; J Ward
Journal:  MMWR CDC Surveill Summ       Date:  1999-04-16

3.  Clarithromycin and ethambutol with or without clofazimine for the treatment of bacteremic Mycobacterium avium complex disease in patients with HIV infection.

Authors:  R E Chaisson; P Keiser; M Pierce; W J Fessel; J Ruskin; C Lahart; C A Benson; K Meek; N Siepman; J C Craft
Journal:  AIDS       Date:  1997-03       Impact factor: 4.177

Review 4.  Nontuberculous mycobacteria in the HIV infected patient.

Authors:  Denis Jones; Diane V Havlir
Journal:  Clin Chest Med       Date:  2002-09       Impact factor: 2.878

5.  AIDS across Europe, 1994-98: the EuroSIDA study.

Authors:  A Mocroft; C Katlama; A M Johnson; C Pradier; F Antunes; F Mulcahy; A Chiesi; A N Phillips; O Kirk; J D Lundgren
Journal:  Lancet       Date:  2000-07-22       Impact factor: 79.321

Review 6.  Mycobacterium avium complex in patients with HIV infection in the era of highly active antiretroviral therapy.

Authors:  Petros C Karakousis; Richard D Moore; Richard E Chaisson
Journal:  Lancet Infect Dis       Date:  2004-09       Impact factor: 25.071

Review 7.  [Cutaneous infections due to atypical mycobacteria].

Authors:  M Streit; T Bregenzer; I Heinzer
Journal:  Hautarzt       Date:  2008-01       Impact factor: 0.751

8.  Association of HIV infection and Mycobacterium ulcerans disease in Benin.

Authors:  Roch C Johnson; Fabienne Nackers; Judith R Glynn; Elisa de Biurrun Bakedano; Claude Zinsou; Julia Aguiar; René Tonglet; Françoise Portaels
Journal:  AIDS       Date:  2008-04-23       Impact factor: 4.177

9.  Development of a simple and low-cost real-time PCR method for the identification of commonly encountered mycobacteria in a high throughput laboratory.

Authors:  K L Leung; C W Yip; W F Cheung; A C T Lo; W M Ko; K M Kam
Journal:  J Appl Microbiol       Date:  2009-04-22       Impact factor: 3.772

10.  Nontuberculous mycobacterial infections of the skin: A retrospective study of 25 cases.

Authors:  Roni Dodiuk-Gad; Pavel Dyachenko; Michael Ziv; Ayelet Shani-Adir; Yehudit Oren; Saul Mendelovici; Jan Shafer; Bibiana Chazan; Raul Raz; Yoram Keness; Dganit Rozenman
Journal:  J Am Acad Dermatol       Date:  2007-03-26       Impact factor: 11.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.